financetom
Business
financetom
/
Business
/
Market Chatter: Irenic Capital Builds Stake in Workiva, Pushes for Board Seats, Possible Sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Irenic Capital Builds Stake in Workiva, Pushes for Board Seats, Possible Sale
Sep 29, 2025 8:19 AM

10:55 AM EDT, 09/29/2025 (MT Newswires) -- Irenic Capital Management has built a roughly 2% stake in Workiva ( WK ) and is pressing the financial reporting software company to improve operating efficiency, refresh its board, and consider a potential sale, Reuters reported Monday, citing documents and people familiar with the matter.

The hedge fund is urging Workiva ( WK ) to collapse its dual-class share structure, hold annual board elections, and add two new directors, including Irenic executive Krishna Korupolu, according to the report. It has also pushed the company to review strategic alternatives amid strong private equity interest in the sector, Reuters said.

Irenic has not ruled out nominating directors if no agreement is reached.

Workiva ( WK ) and Irenic did not immediately respond to MT Newswires' request for comment on the matter.

Shares of Workiva ( WK ) have fallen nearly 19% since Julie Iskow became chief executive officer in April 2023.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 86.66, Change: +0.87, Percent Change: +1.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Amazon Using Streaming Video to Chip Away at Dominance of Allegro in Poland
Market Chatter: Amazon Using Streaming Video to Chip Away at Dominance of Allegro in Poland
Apr 9, 2024
09:00 AM EDT, 04/09/2024 (MT Newswires) -- Amazon ( AMZN ) is seeking to challenge Poland's leading online marketplace Allegro, using its video streaming platform as a way to attract customers, Reuters reported, citing company officials. Amazon ( AMZN ) plans to add more original Polish-language shows to the five it has launched on its Prime Video service since 2023,...
Google Introduces Arm-Based Data Center Processor
Google Introduces Arm-Based Data Center Processor
Apr 9, 2024
08:51 AM EDT, 04/09/2024 (MT Newswires) -- Alphabet's (GOOG, GOOGL) Google ( GOOG ) on Tuesday introduced its first custom Arm-based processor designed for data centers. The chip, called Axion, provides up to 30% better performance compared with the fastest general-purpose Arm-based instances available in the cloud today, Google ( GOOG ) said in a blog post. Google ( GOOG...
Galaxy Digital Holdings Reports C$136.5 Million Bought Deal Public Offering; Jumped 9.5% To 52 Week Highs on Monday
Galaxy Digital Holdings Reports C$136.5 Million Bought Deal Public Offering; Jumped 9.5% To 52 Week Highs on Monday
Apr 9, 2024
08:54 AM EDT, 04/09/2024 (MT Newswires) -- Galaxy Digital Holdings ( BRPHF ) , which jumped 9.5% to 52 week highs yesterday, said Tuesday that it will raise C$136.5 million (near US$100 million) via a bought-deal public offering. Canaccord Genuity is underwriting the offering, which includes almost 9.8 million ordinary shares priced at C$14 each. Some shareholders, including Galaxy Group...
Pfizer Says Phase 3 Trial of Abrysvo for Respiratory Syncytial Virus Disease Meets Primary Endpoints
Pfizer Says Phase 3 Trial of Abrysvo for Respiratory Syncytial Virus Disease Meets Primary Endpoints
Apr 9, 2024
08:57 AM EDT, 04/09/2024 (MT Newswires) -- Pfizer ( PFE ) said Tuesday that its current pivotal phase 3 trial of Abrysvo against placebo in participants aged 18 to 59 years met primary endpoints. The patients were at an increased risk of developing respiratory syncytial virus-associated lower respiratory tract disease, the company said. In the trial, patients attained at least...
Copyright 2023-2026 - www.financetom.com All Rights Reserved